A Study to evaluate the PK, PD, efficacy, and safety of Anifrolumab in children with moderate to severe active SLE
Accepts Healthy Volunteers
Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms |
No |
Study Type
An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes. An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes. Searching Both is inclusive of interventional and observational studies. |
Interventional |
Eligible Ages | 5 Years - 17 Years |
Gender | All |
Trial ID:
This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries. |
NCT05835310 |
Phase
Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans. Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data. Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs. Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use. |
Phase 3 |
Lead Sponsor
The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data. |
AstraZeneca |
Principal Investigator
The person who is responsible for the scientific and technical direction of the entire clinical study. |
N/A |
Principal Investigator Affiliation | N/A |
Agency Class
Category of organization(s) involved as sponsor (and collaborator) supporting the trial. |
Industry |
Overall Status | Recruiting |
Countries | Argentina, Brazil, Canada, China, Colombia, France, Germany, Italy, Japan, Mexico, Poland, Portugal, South Africa, Spain, Turkey (Türkiye), United Kingdom, United States |
Conditions
The disease, disorder, syndrome, illness, or injury that is being studied. |
Systemic Lupus Erythematosus |
This study aims to characterize the pharmacokinetics, pharmacodynamics, efficacy, and safety of Anifrolumab solution for infusion compared with placebo solution for infusion in pediatric participants with severe active systemic lupus erythematosus who are on background standard of care therapy. The study duration for a participant will be approximately 116 weeks, which includes:
Experimental: Anifrolumab
Randomized participants will receive a single dose of Anifrolumab via IV infusion every 4 weeks
Placebo Comparator: Placebo
Randomized participants will receive matching placebo via IV infusion
Biological: - Anifrolumab
Participants will receive a single dose of Anifrolumab via IV infusion.
Drug: - Placebo
Participants will receive matching placebo via IV infusion
If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.
Status
Recruiting
Address
Research Site
Phoenix 5308655, Arizona 5551752, 85016
Status
Recruiting
Address
Research Site
Los Angeles 5368361, California 5332921, 90027
Status
Not yet recruiting
Address
Research Site
Washington D.C. 4140963, District of Columbia 4138106, 20010
Status
Recruiting
Address
Research Site
Chicago 4887398, Illinois 4896861, 60611
Status
Recruiting
Address
Research Site
Chicago 4887398, Illinois 4896861, 60637
Status
Withdrawn
Address
Research Site
Bethesda 4348599, Maryland 4361885, 20889
Status
Recruiting
Address
Research Site
Saint Paul 5045360, Minnesota 5037779, 55125
Status
Recruiting
Address
Research Site
New Hyde Park 5128514, New York 5128638, 11042
Status
Recruiting
Address
Research Site
New York 5128581, New York 5128638, 10032
Status
Recruiting
Address
Research Site
The Bronx 5110266, New York 5128638, 10467
Status
Recruiting
Address
Research Site
Valhalla 5142090, New York 5128638, 10595
Status
Not yet recruiting
Address
Research Site
Durham 4464368, North Carolina 4482348, 27710
Status
Recruiting
Address
Research Site
Cincinnati 4508722, Ohio 5165418, 45229
Status
Recruiting
Address
Research Site
Cleveland 5150529, Ohio 5165418, 44109
Status
Recruiting
Address
Research Site
Columbus 4509177, Ohio 5165418, 43203
Status
Recruiting
Address
Research Site
Portland 5746545, Oregon 5744337, 97227
Status
Recruiting
Address
Research Site
Philadelphia 4560349, Pennsylvania 6254927, 19104
Status
Withdrawn
Address
Research Site
Greenville 4580543, South Carolina 4597040, 29605
Status
Recruiting
Address
Research Site
El Paso 5520993, Texas 4736286, 79902
Status
Recruiting
Address
Research Site
Houston 4699066, Texas 4736286, 77030
Status
Recruiting
Address
Research Site
Salt Lake City 5780993, Utah 5549030, 84108
Status
Withdrawn
Address
Research Site
Buenos Aires 3435910, , C1270
Status
Not yet recruiting
Address
Research Site
Córdoba 3860259, , 5000
Status
Not yet recruiting
Address
Research Site
Rosario 3838583, , S2000PBJ
Status
Recruiting
Address
Research Site
Botucatu 3469136, , 18610-070
Status
Recruiting
Address
Research Site
Curitiba 3464975, , 80030-110
Status
Recruiting
Address
Research Site
Porto Alegre 3452925, , 90035-903
Status
Recruiting
Address
Research Site
Ribeirão Preto 3451328, , 14048-900
Status
Recruiting
Address
Research Site
São Paulo 3448439, , 04024-002
Status
Recruiting
Address
Research Site
São Paulo 3448439, , 05403 000
Status
Recruiting
Address
Research Site
Vancouver 6173331, British Columbia 5909050, V6H 3N1
Status
Recruiting
Address
Research Site
Toronto 6167865, Ontario 6093943, M5G 1X8
Status
Not yet recruiting
Address
Research Site
Beijing 1816670, , 100020
Status
Recruiting
Address
Research Site
Beijing 1816670, , 100730
Status
Recruiting
Address
Research Site
Changchun 2038180, , 130021
Status
Recruiting
Address
Research Site
Changsha 1815577, , 410007
Status
Recruiting
Address
Research Site
Shanghai 1796236, , 201102
Status
Recruiting
Address
Research Site
Suzhou 1886760, , 215002
Status
Recruiting
Address
Research Site
Wenzhou 1791388, , 325027
Status
Recruiting
Address
Research Site
Zhengzhou 1784658, , 450018
Status
Not yet recruiting
Address
Research Site
Barranquilla 3689147, , 01800
Status
Withdrawn
Address
Research Site
Medellín 3674962, , 050034
Status
Recruiting
Address
Research Site
Bordeaux 3031582, , 33076
Status
Recruiting
Address
Research Site
Bron 3029931, , 69677
Status
Recruiting
Address
Research Site
Le Kremlin-Bicêtre 3003737, , 94275
Status
Recruiting
Address
Research Site
Lille 2998324, , 59037
Status
Recruiting
Address
Research Site
Toulouse 2972315, , 31300
Status
Recruiting
Address
Research Site
Berlin 2950159, , D-13353
Status
Recruiting
Address
Research Site
Freiburg im Breisgau 2925177, , 79106
Status
Recruiting
Address
Research Site
Sankt Augustin 2841648, , 53757
Status
Recruiting
Address
Research Site
Genova 8969657, , 16148
Status
Recruiting
Address
Research Site
Milan 6951411, , 20122
Status
Recruiting
Address
Research Site
Padua 3171728, , 35128
Status
Recruiting
Address
Research Site
Roma 8957247, , 00165
Status
Recruiting
Address
Research Site
Bunkyō City 11790632, , 113-8519
Status
Recruiting
Address
Research Site
Bunkyō City 11790632, , 113-8603
Status
Recruiting
Address
Research Site
Chiba 2113015, , 266-0007
Status
Recruiting
Address
Research Site
Fuchu-shi, , 183-8561
Status
Recruiting
Address
Research Site
Kawasaki-shi, , 216-8511
Status
Recruiting
Address
Research Site
Kobe 1859171, , 650-0047
Status
Recruiting
Address
Research Site
Obu-shi, , 474-8710
Status
Recruiting
Address
Research Site
Shinjuku-ku, , 162-8666
Status
Recruiting
Address
Research Site
Yokohama 1848354, , 232 8555
Status
Recruiting
Address
Research Site
Yokohama 1848354, , 236-0004
Status
Not yet recruiting
Address
Research Site
Guadalajara 4005539, , 44620
Status
Not yet recruiting
Address
Research Site
Mexico 11095662, , 06720
Status
Recruiting
Address
Research Site
Mérida 3523349, , 97070
Status
Not yet recruiting
Address
Research Site
Monterrey 3995465, , 64460
Status
Not yet recruiting
Address
Research Site
Toluca 3515302, , 50170
Status
Recruiting
Address
Research Site
Lodź, , 91-738
Status
Recruiting
Address
Research Site
Warsaw 756135, , 02-637
Status
Recruiting
Address
Research Site
Wroclaw 3081368, , 52-114
Status
Suspended
Address
Research Site
Lisbon 2267057, , 1169-045
Status
Suspended
Address
Research Site
Lisbon 2267057, , 1649-035
Status
Suspended
Address
Research Site
Porto 2735943, , 4200-319
Status
Withdrawn
Address
Research Site
Cape Town 3369157, , 7700
Status
Recruiting
Address
Research Site
Esplugues de Llobregat 3122826, , 8950
Status
Recruiting
Address
Research Site
Madrid 3117735, , 28009
Status
Recruiting
Address
Research Site
Madrid 3117735, , 28034
Status
Recruiting
Address
Research Site
Málaga 2514256, , 29011
Status
Recruiting
Address
Research Site
Valencia 2509954, , 46026
Status
Recruiting
Address
Research Site
Ankara 323786, , 06230
Status
Recruiting
Address
Research Site
Istanbul 745044, , 34098
Status
Recruiting
Address
Research Site
Kayseri 308464, , 38039
Status
Recruiting
Address
Research Site
Umraniye 738377, , 34760
Status
Not yet recruiting
Address
Research Site
Birmingham 2655603, , B4 6NH
Status
Not yet recruiting
Address
Research Site
Bristol 2654675, , BS2 8BJ
Status
Recruiting
Address
Research Site
Liverpool 2644210, , L12 2AP
Status
Recruiting
Address
Research Site
London 2643743, , NW1 2PG
Status
Recruiting
Address
Research Site
London 2643743, , WC1N 3JH
Status
Not yet recruiting
Address
Research Site
Manchester 2643123, , M13 9WL
Status
Recruiting
Address
Research Site
Southampton 2637487, , SO16 6YD